Skip to content

Clinical Investigation of Non-Absorbable Sutures, Skin Stapler and Catridge in surgery for skin closure.

Post Market Clinical Follow Up study of Non-Absorbable Sutures, Skin Stapler and Cartridge.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039306
Enrollment
300
Registered
2022-01-10
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Non Absorbable Surgical Sutures,Skin Stapler and Cartidge: The non absorbable sutures should be selected and implanted depending on patientâ??s condition, surgical experience, surgical

Sponsors

Futura Surgicare Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Informed consent from the subject Subjects using the Non-absorbable sutures for general surgery, soft tissue approximation and ligation. Adult patient who are >= 18 age.

Exclusion criteria

Exclusion criteria: Subjects without informed consent from the subject. Subjects in which permanent retention of tensile strength is required. Subject who are sensitive or allergic to the raw materials of the sutures.

Design outcomes

Primary

MeasureTime frame
The primary objective of this post market clinical study is to assess the clinical performance, safety and acceptability of the Non-Absorbable Suture, Skin stapler and cartridge. Endpoints: - Quantitative determination of soft tissue approximation/ligation and wound closure action by using the non-Absorbable surgical suture and surgical skin stapler - Occurrence of wound reopening - Occurrence of wound re-rupturing after hand surgery - Any signs of superficial infection after surgery â?? Redness, Pus, Swelling - Ease of use using Likertâ??s scale (1-5) - Ease of removal using Likertâ??s Scale (1-5) Timepoint: 6 to 12 months

Secondary

MeasureTime frame
The Secondary Objective is to determine any undesirable events under normal condition of use and identify the presence of any new emergent risks, known and unknown residual risk. The study will focus on identifying possible systematic misuse or off-label use of the device. Timepoint: 6 to 12 months

Countries

India

Contacts

Public ContactDr Murali Mohan S

Sagar Hospitals

drmurali78@gmail.com9483861505

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026